Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05522972 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05522972 · ClinicalTrials.gov record · last posted 2025-12-16

Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games

StatusRecruiting
PhaseNot applicable
Started2022-09-13
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.

Amendment record 4 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 4 times since 2022-08-29; most recent amendment 2025-12-08. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-09-13
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05522972
Lead Sponsor Nova Southeastern University
Conditions Amblyopia
Enrollment 180 participants
Start Date 2022-09-13
Primary Completion 2029-08-31 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16